Live Breaking News & Updates on Biocon stock price

Stay informed with the latest breaking news from Biocon stock price on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biocon stock price and stay connected to the pulse of your community

Jefferies downgrades Biocon to 'underperform', sees 11% downside; here's why

Jefferies has downgraded the pharma stock Biocon to 'underperform' from 'hold'. However, Jefferies has maintained its target price of ₹250 for the stock, implying an 11 percent downside from its current market price of ₹281.50.

Malaysia , Bangalore , Karnataka , India , Biocon-biologics , Biocon , Economic-times , Biocon-stock , Biocon-share-price , Biocon-shares , Biocon-stock-price , Jefferies-on-biocon

Biocon Share Price Falls 9% After Q3 Profit Dips 18% YoY To Rs 186 Crore

Biocon Share Price Falls 9% After Q3 Profit Dips 18% YoY To Rs 186 Crore
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.

Kiran-mazumdar-shaw , Biocon , Biocon-share-price , Biocon-stock-price , Biocon-news , Biocon-q3 , Buzzing-stock , கிறன்-மஜும்தர்-ஷா , பயோகான் , பயோகான்-பகிர்-ப்ரைஸ் , பயோகான்-ஸ்டாக்-ப்ரைஸ்

Biocon Share Price News: Biocon Shares Fall After Profit Declines In December Quarter

Biocon Shares Fall After Profit Declines In December Quarter
On a standalone basis, Biocon's profit plunged 72 per cent annually to Rs 33 crore from Rs 121 crore during the same period last year.
Updated: January 22, 2021 11:32 am IST
Shares of drug maker - Biocon - fell as much as 10 per cent to hit an intraday low of Rs 399 on the BSE after its consolidated net profit declined 19 per cent to Rs 187 crore in quarter ended December 2020 from Rs 230 crore during the corresponding period a year ago. Its consolidated revenue from operations however, rose 8 per cent to Rs 1,851 crore.
On a standalone basis, Biocon's profit plunged 72 per cent annually to Rs 33 crore from Rs 121 crore during the same period last year.

Kiran-mazumdar-shaw , Biocon-biologics , Research-services , Biocon , Goldman-sachs , Executive-chairperson , Net-profit , Biocon-shares-price , Biocon-stock-price , Biocon-shares , கிறன்-மஜும்தர்-ஷா , பயோகான்-உயிரியல்